{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T23:17:20Z","timestamp":1649027840125},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartlungcirc.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.hlc.2017.02.015","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T16:56:07Z","timestamp":1490201767000},"page":"183-189","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Pulmonary Capillary Wedge Pressure on Long-Term Mortality in Patients With Pulmonary Arterial Hypertension Treated With Parenteral Trepostinil"],"prefix":"10.1016","volume":"27","author":[{"given":"Jignesh K.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youlan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Strachan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.hlc.2017.02.015_bib0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1378\/chest.14-0793","article-title":"Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report","volume":"146","author":"Taichman","year":"2014","journal-title":"Chest"},{"issue":"25 Suppl","key":"10.1016\/j.hlc.2017.02.015_bib0010","doi-asserted-by":"crossref","first-page":"D51","DOI":"10.1016\/j.jacc.2013.10.023","article-title":"Pulmonary arterial hypertension: epidemiology and registries","volume":"62","author":"McGoon","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"1 Suppl","key":"10.1016\/j.hlc.2017.02.015_bib0015","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hlc.2017.02.015_bib0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension:. Results from a national prospective registry","volume":"115","author":"D\u2019Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hlc.2017.02.015_bib0025","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.hlc.2017.02.015_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1378\/chest.11-1387","article-title":"Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mmHg: insights from the REVEAL registry","volume":"143","author":"Frost","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.hlc.2017.02.015_bib0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-8703(97)70105-4","article-title":"A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)","volume":"134","author":"Califf","year":"1997","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.hlc.2017.02.015_bib0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.healun.2009.09.005","article-title":"Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial","volume":"29","author":"Hiremath","year":"2010","journal-title":"J Heart Lung Transplant Off Publ Int Soc Heart Transplant"},{"issue":"6","key":"10.1016\/j.hlc.2017.02.015_bib0045","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.hlc.2017.02.015_bib0050","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1183\/09031936.06.00044406","article-title":"Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil","volume":"28","author":"Barst","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2017.02.015_bib0055","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2017.02.015_bib0060","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1183\/09031936.06.00044406","article-title":"Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil","volume":"28","author":"Barst","year":"2006","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.hlc.2017.02.015_bib0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1378\/chest.12-2417","article-title":"Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry","volume":"144","author":"Barst","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2017.02.015_bib0070","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.healun.2011.03.011","article-title":"Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials","volume":"30","author":"Benza","year":"2011","journal-title":"The Journal of Heart and Lung Transplantation: the official publication of the International Society for Heart Transplantation"},{"key":"10.1016\/j.hlc.2017.02.015_bib0075","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/1074248414568195","article-title":"Predicting the Need for Upfront Combination Therapy in Pulmonary Arterial Hypertension","volume":"20","author":"Bajwa","year":"2015","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"June (6)","key":"10.1016\/j.hlc.2017.02.015_bib0080","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.healun.2015.12.028","article-title":"Right atrial pressure\/pulmonary artery wedge pressure ratio: A more specific predictor of survival in pulmonary arterial hypertension","volume":"35","author":"Fares","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.hlc.2017.02.015_bib0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/675994","article-title":"Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension","volume":"4","author":"\u200bBenson","year":"2014","journal-title":"Pulmonary Circulation"},{"issue":"1","key":"10.1016\/j.hlc.2017.02.015_bib0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1378\/chest.11-3241","article-title":"Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis","volume":"144","author":"Poms","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2017.02.015_bib0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1378\/chest.13-3035","article-title":"Echocardiographic assessment of estimated right atrial pressure and size predicts mortality in pulmonary arterial hypertension","volume":"147","author":"Austin","year":"2015","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.hlc.2017.02.015_bib0100","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/acr.22121","article-title":"Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry","volume":"66","author":"Chung","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.hlc.2017.02.015_bib0105","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1378\/chest.14-0809","article-title":"Elevation of plasma cell-free hemoglobin in pulmonary arterial hypertension","volume":"146","author":"Brittain","year":"2014","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.hlc.2017.02.015_bib0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1378\/chest.12-0270","article-title":"Baseline and follow-up 6-min walk distance and brain natriuretic peptide predict 2-year mortality in pulmonary arterial hypertension","volume":"143","author":"Fritz","year":"2013","journal-title":"Chest"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950617301191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950617301191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T04:55:58Z","timestamp":1535950558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950617301191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1443950617301191"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2017.02.015","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Pulmonary Capillary Wedge Pressure on Long-Term Mortality in Patients With Pulmonary Arterial Hypertension Treated With Parenteral Trepostinil","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2017.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}